Clinical trial
Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary Artery Lesion (NeoVas): Randomized Controlled Trial
NCT02305485 is registered in ClinicalTrials.gov with Lepu Medical Technology (Beijing) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary Artery Lesion (NeoVas): Randomized Controlled Trial
- Lead sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- June 30, 2020
- Enrollment
- 560 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.